🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Status
Unknown
Location
Dong-A University Hospital
Start Date
2015-02
Trial ID
NCT02431403
Treatments Being Tested
Radical cystectomy remains the gold standard treatment for invasive non met...
Status
Completed
Location
UHRouen
Start Date
2013-02
Trial ID
NCT01812369
Treatments Being Tested
The purpose of this study is to determine whether BP-C1 is effective in the...
Status
Completed
Location
Russian Oncological Research Centre n.a. N.N. Blokhin, Russian Academy of Medical Science (RAMS)
Start Date
2012-12-24
Trial ID
NCT02783794
This phase I/II trial studies the side effects and best dose of sirolimus w...
Status
Completed
Location
VA Puget Sound Health Care System
Start Date
2013-10
Trial ID
NCT01938573
Treatments Being Tested
Immunotherapeutic approaches recently have demonstrated clinical efficacy i...
Status
Recruiting
Location
Aix-en-Provence - CH
Start Date
2022-05-02
Trial ID
NCT05255302
Treatments Being Tested
The purpose of this study is to assess efficacy and safety of docetaxel alo...
Status
Unknown
Location
Research Institute and Hospital, National Cancer Center Korea
Start Date
2008-11
Trial ID
NCT00980603
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2003-04
Trial ID
NCT00054054
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
1998-03
Trial ID
NCT00003322
Treatments Being Tested
This phase I trial studies the side effects and how well surgery and heated...
Status
Active Not Recruiting
Location
City of Hope Corona
Start Date
2014-05-19
Trial ID
NCT01970722
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501